We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$14.8B
AUM Growth
+$1.53B
(+12%)
Cap. Flow
+$575M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
20.47%
Holding
2,662
New
208
Increased
1,251
Reduced
990
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$56.7M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$43.4M |
| 3 |
Vanguard Extended Market ETF
VXF
|
+$41.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$39.4M |
| 5 |
Apple
AAPL
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
C.H. Robinson
CHRW
|
+$26.2M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$25.5M |
| 3 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$20.6M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$18.6M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.79% |
| 2 | Consumer Discretionary | 5% |
| 3 | Healthcare | 4.52% |
| 4 | Financials | 4.2% |
| 5 | Communication Services | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
FS Bancorp
FSBW
$326M
| $462K | ﹤0.01% |
22,554
-758
| -3% | -$14.7K |
|
1652
UGI
UGI
$7.56B
| $462K | ﹤0.01% |
14,008
-25
| -0.2% | -$829 |
|
1653
BHP
BHP
$222B
| $461K | ﹤0.01% |
9,987
+2,122
| +27% | +$102K |
|
1654
Inseego
INSG
$77.7M
| $460K | ﹤0.01% |
4,456
-1,157
| -21% | -$134K |
|
|
ERC
1655
Allspring Multi-Sector Income Fund
ERC
$259M
| $459K | ﹤0.01% |
42,715
-3,969
| -9% | -$44.6K |
|
1656
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$283M
| $458K | ﹤0.01% |
10,268
+2,163
| +27% | +$94.7K |
|
1657
WisdomTree Europe Quality Dividend Growth Fund
EUDG
$70M
| $456K | ﹤0.01% |
16,503
+2,690
| +19% | +$73.6K |
|
1658
Renaissance International IPO ETF
IPOS
$11.8M
| $456K | ﹤0.01% |
+14,131
| New | +$453K |
|
1659
First Trust Long/Short Equity ETF
FTLS
$2.5B
| $455K | ﹤0.01% |
10,683
-1,310
| -11% | -$56K |
|
1660
Jazz Pharmaceuticals
JAZZ
$16B
| $455K | ﹤0.01% |
+3,193
| New | +$396K |
|
1661
Innovator US Equity Power Buffer ETF November
PNOV
$898M
| $455K | ﹤0.01% |
16,767
+397
| +2% | +$10.6K |
|
|
MNDT
1662
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $455K | ﹤0.01% |
36,863
+10,108
| +38% | +$138K |
|
|
COR
1663
DELISTED
Coresite Realty Corporation
COR
| $454K | ﹤0.01% |
3,819
-106
| -3% | -$12.9K |
|
|
DNKN
1664
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $454K | ﹤0.01% |
5,548
-6,131
| -52% | -$443K |
|
|
AVK
1665
Advent Convertible and Income Fund
AVK
$577M
| $453K | ﹤0.01% |
33,698
-1,498
| -4% | -$20.3K |
|
1666
AXIS Capital
AXS
$7.3B
| $453K | ﹤0.01% |
10,287
+2,293
| +29% | +$99.9K |
|
1667
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $452K | ﹤0.01% |
11,148
-5,087
| -31% | -$211K |
|
1668
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$346M
| $452K | ﹤0.01% |
33,919
+17,394
| +105% | +$234K |
|
1669
Alcoa
AA
$13.1B
| $450K | ﹤0.01% |
38,718
-5,264
| -12% | -$70.7K |
|
1670
Virtus Private Credit Strategy ETF
VPC
$32M
| $450K | ﹤0.01% |
25,130
-642
| -2% | -$11.6K |
|
1671
Whirlpool
WHR
$2.79B
| $450K | ﹤0.01% |
2,448
-103
| -4% | -$17.1K |
|
1672
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $449K | ﹤0.01% |
9,759
+866
| +10% | +$39.9K |
|
1673
United Bankshares
UBSI
$6.68B
| $449K | ﹤0.01% |
20,900
+1,890
| +10% | +$49.2K |
|
|
DRE
1674
DELISTED
Duke Realty Corp.
DRE
| $449K | ﹤0.01% |
12,165
-1,581
| -12% | -$59.5K |
|
1675
Mercury Insurance
MCY
$5.81B
| $448K | ﹤0.01% |
10,833
+568
| +6% | +$24.4K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Cambridge Investment Research Advisors held 2,662 positions worth $14.8B, up 12% from $13.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $575M of net new capital in Q3 2020, opening 208 new positions and adding to 1,251 existing holdings. Its largest new stake was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was C.H. Robinson, an estimated $26.2M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2020 buy was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
- Cambridge Investment Research Advisors added most to Bristol-Myers Squibb in Q3 2020, an estimated $56.7M increase.
- Cambridge Investment Research Advisors's biggest Q3 2020 reduction was C.H. Robinson, cutting an estimated $26.2M.
- Cambridge Investment Research Advisors fully exited WisdomTree International ESG Fund in Q3 2020, selling an estimated $11.4M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $14.8B portfolio in Q3 2020.
- Cambridge Investment Research Advisors opened 208 new positions and closed 149 in Q3 2020.
- Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $14.8B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.